Colgate Palmolive (CL) Liabilities and Shareholders Equity (2009 - 2026)

Colgate Palmolive's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $16.6 billion for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity changed 0.22% year-over-year to $16.6 billion in Q1 2026; TTM through Mar 2026 was $67.9 billion, a 3.0% increase from a year earlier, with the FY2025 full-year figure at $16.3 billion, up 1.77% from the prior year.
• Liabilities and Shareholders Equity rose to $16.6 billion in Q1 2026 per CL's latest filing, from $16.3 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $17.5 billion in Q3 2025 and bottomed at $15.7 billion in Q2 2022.
• The 5-year median for Liabilities and Shareholders Equity is $16.3 billion (2025), against an average of $16.4 billion.
• Across the five-year window, Liabilities and Shareholders Equity retreated 2.12% in 2024 and gained 6.01% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $15.7 billion in 2022, then gained by 4.21% to $16.4 billion in 2023, then slipped by 2.12% to $16.0 billion in 2024, then gained by 1.77% to $16.3 billion in 2025, then grew by 1.71% to $16.6 billion in 2026.
• Per Business Quant, the three latest CL Liabilities and Shareholders Equity figures stand at $16.6 billion (Q1 2026), $16.3 billion (Q4 2025), and $17.5 billion (Q3 2025).